Clozapine in treatment-resistant schizophrenia: Authors' reply
File version
Author(s)
McCartney, Lara
Kisely, Steve
Griffith University Author(s)
Primary Supervisor
Other Supervisors
Editor(s)
Date
Size
File type(s)
Location
License
Abstract
We agree with Samara and Leucht that clinicians can feel overwhelmed by the vast quantity of published meta-analyses and variety of methodologies. It is therefore important that protocols for potential meta-analyses are published on open access repositories such as PROSPERO to reduce the risk of duplication. Unfortunately, we were unaware of the 2016 Samara et al meta-analysis at the time of conducting ours, as they did not register their protocol on PROSPERO, only including a protocol as a supplementary document at the time of publication.
Journal Title
British Journal of Psychiatry
Conference Title
Book Title
Edition
Volume
210
Issue
4
Thesis Type
Degree Program
School
Publisher link
Patent number
Funder(s)
Grant identifier(s)
Rights Statement
Rights Statement
Item Access Status
Note
Access the data
Related item(s)
Subject
Biomedical and clinical sciences
Psychology
Science & Technology
Life Sciences & Biomedicine
Psychiatry
ANTIPSYCHOTICS
Persistent link to this record
Citation
Siskind, D; McCartney, L; Kisely, S, Clozapine in treatment-resistant schizophrenia: Authors' reply, British Journal of Psychiatry, 2017, 210 (4), pp. 299-300